1 April 2001 Advances in contrast agents, reporters, and detection
Author Affiliations +
The use of exogenous probes to gain a deeper understanding of physiological and molecular processes in vivo through the acquisition of optical signals, particularly via enhanced contrast using molecular probes ~physiologically transported, site-directed, or via reporter genes! has emerged with tremendous vigor in the past few years. One such area of expanded activity is in the area of early cancer detection, in great part because it is so critical to the clinical outcome in the treatment.1–3 As an example, in colon cancer, which accounts for 15% of all U.S. cancer-related deaths, only 37% are found early enough for moderate treatment1 and once these types of cancer reach metastatic activity the survival rate is only 7%.
© (2001) Society of Photo-Optical Instrumentation Engineers (SPIE)
Darryl J. Bornhop, Darryl J. Bornhop, Christopher H. Contag, Christopher H. Contag, Kai Licha, Kai Licha, Catherine J. Murphy, Catherine J. Murphy, } "Advances in contrast agents, reporters, and detection," Journal of Biomedical Optics 6(2), (1 April 2001). https://doi.org/10.1117/1.1360394 . Submission:

Back to Top